Plus Therapeutics (PSTV) Insider Trading & Ownership $1.20 +0.00 (+0.01%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.18 -0.02 (-1.33%) As of 02/21/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Plus Therapeutics (NASDAQ:PSTV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.49%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$82,744.90Number OfInsiders Selling(Last 12 Months)0 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PSTV Insider Buying and Selling by Quarter Plus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/13/2024Richard J HawkinsDirectorBuy4,000$1.50$6,000.00 9/11/2024Howard ClowesDirectorBuy5,000$1.34$6,700.00 9/10/2024Andrew John Hugh Macintyr SimsCFOBuy4,098$1.27$5,204.46 9/10/2024Marc H HedrickCEOBuy8,000$1.23$9,840.00 5/8/2024Andrew John Hugh Macintyr SimsCFOBuy4,902$2.04$10,000.08 5/8/2024Howard ClowesDirectorBuy9,804$2.04$20,000.16 5/8/2024Marc H HedrickCEOBuy12,255$2.04$25,000.20 (Data available from 1/1/2013 forward) PSTV Insider Trading Activity - Frequently Asked Questions Who is on Plus Therapeutics's Insider Roster? The list of insiders at Plus Therapeutics includes Andrew John Hugh Macintyr Sims, Greg Petersen, Howard Clowes, Marc H Hedrick, Richard J Hawkins, and Robert P Lenk. Learn more on insiders at PSTV. What percentage of Plus Therapeutics stock is owned by insiders? 5.49% of Plus Therapeutics stock is owned by insiders. Learn more on PSTV's insider holdings. Which Plus Therapeutics insiders have been buying company stock? The following insiders have purchased PSTV shares in the last 24 months: Andrew John Hugh Macintyr Sims ($15,204.54), Greg Petersen ($34,000.00), Howard Clowes ($49,780.15), Marc H Hedrick ($34,840.20), Richard J Hawkins ($6,000.00), and Robert P Lenk ($20,732.50). How much insider buying is happening at Plus Therapeutics? Insiders have purchased a total of 91,947 PSTV shares in the last 24 months for a total of $160,557.39 bought. Which Plus Therapeutics insiders have been selling company stock? The following insider sold PSTV shares in the last 24 months: Marc H Hedrick ($4,053.28). How much insider selling is happening at Plus Therapeutics? Insiders have sold a total of 2,068 Plus Therapeutics shares in the last 24 months for a total of $4,053.28 sold. Plus Therapeutics Key ExecutivesDr. Marc H. Hedrick M.B.A. (Age 61)M.D., President, CEO & Director Compensation: $945.34kMr. Andrew J. Sims CPA (Age 51)VP of Finance & CFO Compensation: $498.51kDr. Norman D. LaFrance FACNP (Age 76)FACP, M.D., Chief Medical Officer & Senior VP Compensation: $646.02kMs. Desiree Smith (Age 60)Corporate Controller, Principal Financial & Accounting Officer Dr. John K. Fraser (Age 63)Chief Scientist More Insider Trading Tools from MarketBeat Related Companies IRIX Insider Ownership NXGL Insider Ownership RVP Insider Ownership DRIO Insider Ownership VVOS Insider Ownership CODX Insider Ownership LFWD Insider Ownership BSGM Insider Ownership NEPH Insider Ownership PETV Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:PSTV) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
